中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
13期
106-107
,共2页
立普妥%脑梗死%颈动脉粥样硬化斑块
立普妥%腦梗死%頸動脈粥樣硬化斑塊
립보타%뇌경사%경동맥죽양경화반괴
Atorvastatin%Cerebral infarction patients%Carotid atherosclerotic plaque
目的:探讨阿托伐他汀(立普妥)治疗脑梗死患者颈动脉粥样硬化斑块的效果。方法选择2008年11月~2014年11月我院收治的脑梗死患者150例,对照组给予常规治疗,治疗组在此基础上加用立普妥治疗,治疗周期为4周。结果所有患者都完成治疗,两组治疗后颈动脉内膜中层厚度和斑块面积都低于治疗前(P<0.05),同时治疗后治疗组的颈动脉内膜中层厚度和斑块面积低于对照组(P<0.05)。结论立普妥治疗脑梗死患者能有效改善颈动脉粥样硬化斑块状况。
目的:探討阿託伐他汀(立普妥)治療腦梗死患者頸動脈粥樣硬化斑塊的效果。方法選擇2008年11月~2014年11月我院收治的腦梗死患者150例,對照組給予常規治療,治療組在此基礎上加用立普妥治療,治療週期為4週。結果所有患者都完成治療,兩組治療後頸動脈內膜中層厚度和斑塊麵積都低于治療前(P<0.05),同時治療後治療組的頸動脈內膜中層厚度和斑塊麵積低于對照組(P<0.05)。結論立普妥治療腦梗死患者能有效改善頸動脈粥樣硬化斑塊狀況。
목적:탐토아탁벌타정(립보타)치료뇌경사환자경동맥죽양경화반괴적효과。방법선택2008년11월~2014년11월아원수치적뇌경사환자150례,대조조급여상규치료,치료조재차기출상가용립보타치료,치료주기위4주。결과소유환자도완성치료,량조치료후경동맥내막중층후도화반괴면적도저우치료전(P<0.05),동시치료후치료조적경동맥내막중층후도화반괴면적저우대조조(P<0.05)。결론립보타치료뇌경사환자능유효개선경동맥죽양경화반괴상황。
Objective To discuss the ef ect of atorvastatin in treatment of carotid atherosclerotic plaque in patients with cerebral infarction. Methods 150 cases of cerebral infarction patients were select from November 2008 to November 2014 in our hospital. The control group was given conventional therapy while treatment group was added atorvastatin,the treatment period was 4 weeks. Results Al patients completed treatment. After treatment,the carotid intima-media thickness and plaque area were significantly lower than before treatment(P<0.05). And carotid intima-media thickness and plaque area of treatment group were obviously lower than that of control group (P<0.05). Conclusion The use of atorvastatin for treatment in patients with cerebral infarction can ef ectively improve the state of carotid atherosclerotic plaque.